Shira Potter, Editor

About the Author Shira Potter, Editor

Shira Potter is a third year communications student at The Interdisciplinary Center Herzliya (IDC). She is pursuing a career in media content, social media and advertising.

FBR Optimistic on Novavax, Inc. (NVAX) Following Management Meeting

FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and …

Read more

William Blair Heads to Sidelines on CoLucid Pharmaceuticals Inc (CLCD)

William Blair analyst Tim Lugo is downgrading CoLucid (NASDAQ:CLCD) following the announcement of the firm’s …

Read more

William Blair Adds Netflix, Inc. (NFLX) To Better Values List

William Blair analyst Ralph Schackart offers a bullish take on Netflix, Inc. (NASDAQ:NFLX) after adding the …

Read more

Top Mizuho Analyst Sounds the Alarm on Eagle Pharmaceuticals Inc (EGRX) and Cuts Price Target; Shares Plunge 13%

Top analyst Irina Rivkind Koffler at Mizuho is taking a sharp left from the sidelines …

Read more

FBR Weighs in on Volatile Stocks: Kite Pharma Inc (KITE) and Agile Therapeutics Inc (AGRX)

The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for …

Read more

Mizuho Maintains Bullish View on Allergan plc Ordinary Shares (AGN) Following Positive Phase III Data Read-Out for Competitor Sun Pharmaceuticals Industries Limited (SUNPHARMA)

Mizuho analyst Irina Rivkind Koffler chimes in on Allergan plc Ordinary Shares (NYSE:AGN) on back of key …

Read more

BTIG Steps to Sidelines on Bancorp Inc (TBBK); Shares Fall 5%

BTIG analyst Mark Palmer is stepping left and downgrading Bancorp Inc (NASDAQ:TBBK) from a Buy to a …

Read more

J. P. Morgan Analyst Sees Reason to Cheer Biogen Inc (BIIB) Following Early Approval of Drug Spinraza in SMA

J.P. Morgan analyst Cory Kasimov is out singing the praises of Biogen Inc (NASDAQ:BIIB) believing the FDA …

Read more

Revenues Double But So Do Losses for Amazon.com, Inc. (AMZN) India: Baird Top Analyst

Baird top analyst Colin Sebastian puts in his two cents on Amazon.com, Inc. (NASDAQ:AMZN) after the …

Read more

Cantor Signals Caution on Seattle Genetics, Inc (SGEN) Following Partial FDA Hold on AML Drug

Cantor analyst Mara Goldstein sheds light on Seattle Genetics, Inc. (NASDAQ:SGEN) after the bad news broke …

Read more